24小时热门版块排行榜    

查看: 1367  |  回复: 10
【奖励】 本帖被评价5次,作者babyvox6131增加金币 5 个

babyvox6131

金虫 (小有名气)


[资源] 【经验分享】好多人要plans,贴这里了,就不一一发送了 已有4人参与

Research  Plan


Polysaccharides are the most abundant biopolymers in nature that are biosynthesized in a template-independent fashion. Their uses as material and energy sources have been widely appreciated, whereas their roles in mediating signal transduction events in living system only gained attentions recently. Bioactivities of polysaccharide are often size and sequence dependent. Examples include, but are not limited to, the antitumor and immunomodulatory activities of beta-glucan, chitin and chitosan, the neurological activities of polysialic acid, chondroitin sulfate and dermatan sulfate proteoglycans and angiogenic activities of heparin sulfate and hyaluronic acid. Many signaling pathways associated with polysaccharides remain poorly understood. Lack of ready access to size and sequence defined polysaccharide fragment and related chemical tools accounts for this knowledge gap.

    Therefore this proposed work seeks to develop and conceptualize a novel approach for rapid access of sequence-defined polysaccharide fragments that can be readily applied to subsequent biological application for dissecting the signaling pathways related to their biological activities. We plan to integrate synthetic organic chemistry for substrate engineering and protein biochemistry for enzyme engineering to evolve this oligosaccharide synthesis platform. The ultimate goal is to transform this platform into a “Glyco-PCR” machine that is widely applicable to the controlled synthesis of therapeutically important polysaccharide of any size for ready downstream biochemical and biomedical investigations. Our initial application of this platform is to dissect the precise mechanism underlying the observed antitumor and immunomodulatory activity of beta-glucan and chitin/chitosan oligosaccharides. This investigation is expected to lead to novel cancer therapeutics and potential solution for the treatment of autoimmune disease such as asthma.
-------------------------------------------

Return Plan



Chemical biology, especially carbohydrate chemical biology, as one of the most fascinating interdisciplinary fields, has appeared in US & Europe since 1990’s. Now this discipline has emerged as a new research frontier and received more and more attention in the world. However, in China, carbohydrate chemical biology has only received little attention compared to overseas. In many universities and institutes, nobody concentrates on carbohydrate chemical biology. So plenty of researchers will be needed to work on this discipline in the near future.

With good expertise in synthetic chemistry especially carbohydrate chemistry acquired in Shanghai Institute of Organic Chemistry in last five years and a deeper insight into carbohydrate chemical biology that will be acquired in Pittsburgh, I am full of confidence that after the completion of my post-doctorial research program, I will be able to find a suitable academic position in some university or institute in littoral of China or my home province. With good training in US and profound knowledge in chemical biology, I am confident of myself that I will be more competitive and have a much better chance in China.
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

onceaday

金虫 (著名写手)


★★★★★ 五星级,优秀推荐

楼上斑竹可以不说话?
7楼2010-07-14 00:08:39
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zyande

新虫 (初入文坛)


谢谢楼主
10楼2010-09-09 16:05:12
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hncsmuchong

木虫 (正式写手)


★★★★★ 五星级,优秀推荐

谢谢楼主
11楼2010-09-13 10:56:21
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
简单回复
2010-06-19 10:22   回复  
小木虫(金币+0.5):给个红包,谢谢回帖交流
2010-06-19 14:14   回复  
小木虫(金币+0.5):给个红包,谢谢回帖交流
shmeng4楼
2010-06-19 15:45   回复  
小木虫(金币+0.5):给个红包,谢谢回帖交流
2010-06-21 15:01   回复  
kong09086楼
2010-06-22 12:21   回复  
 
zy848308楼
2010-07-14 22:24   回复  
 
keleba9楼
2010-08-06 15:49   回复  
 谢谢分享!
相关版块跳转 我要订阅楼主 babyvox6131 的主题更新
☆ 无星级 ★ 一星级 ★★★ 三星级 ★★★★★ 五星级
普通表情 龙 兔 虎 猫 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考研] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +5 xvJS1BYDxvBS 2026-10-31 12/600 2026-11-02 03:11 by xzcv0Tehd8lQ
[找工作] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +5 1uaZt2kAZj2S 2026-10-31 9/450 2026-11-02 03:05 by xzcv0Tehd8lQ
[公派出国] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +6 1uaZt2kAZj2S 2026-10-31 9/450 2026-11-02 03:00 by xzcv0Tehd8lQ
[基金申请] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +4 1uaZt2kAZj2S 2026-10-30 16/800 2026-11-02 02:58 by xzcv0Tehd8lQ
[公派出国] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +4 1uaZt2kAZj2S 2026-10-30 16/800 2026-11-02 02:45 by xzcv0Tehd8lQ
[基金申请] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +7 X5bHxOULxFqb 2026-10-30 24/1200 2026-11-02 02:39 by xzcv0Tehd8lQ
[基金申请] 售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急 +3 hKe7U1kad5Sg 2026-10-31 6/300 2026-11-01 22:11 by xzcv0Tehd8lQ
[考博] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +4 xvJS1BYDxvBS 2026-10-31 7/350 2026-11-01 22:01 by xzcv0Tehd8lQ
[考博] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +5 1uaZt2kAZj2S 2026-10-31 7/350 2026-11-01 21:45 by xzcv0Tehd8lQ
[考博] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +5 1uaZt2kAZj2S 2026-10-30 17/850 2026-11-01 21:26 by xzcv0Tehd8lQ
[教师之家] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +6 X5bHxOULxFqb 2026-10-30 16/800 2026-11-01 21:19 by xzcv0Tehd8lQ
[论文投稿] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +3 hKe7U1kad5Sg 2026-10-31 5/250 2026-11-01 20:03 by xzcv0Tehd8lQ
[博后之家] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +4 1uaZt2kAZj2S 2026-10-31 8/400 2026-11-01 16:58 by BCdvBAEpt3zm
[考研] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +4 1uaZt2kAZj2S 2026-10-31 8/400 2026-11-01 12:38 by BCdvBAEpt3zm
[考博] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +3 1uaZt2kAZj2S 2026-10-30 10/500 2026-11-01 12:27 by BCdvBAEpt3zm
[考研] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +3 1uaZt2kAZj2S 2026-10-30 16/800 2026-11-01 12:14 by BCdvBAEpt3zm
[硕博家园] 售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急 +4 X5bHxOULxFqb 2026-10-30 18/900 2026-11-01 12:11 by BCdvBAEpt3zm
[考博] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +3 xvJS1BYDxvBS 2026-10-31 4/200 2026-11-01 11:01 by BCdvBAEpt3zm
[论文投稿] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +5 X5bHxOULxFqb 2026-10-30 26/1300 2026-11-01 10:22 by BCdvBAEpt3zm
[论文投稿] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +3 1uaZt2kAZj2S 2026-10-31 8/400 2026-11-01 03:59 by YXM1FDCSE8Bn
信息提示
请填处理意见